Lab-on-a-chip technology measures cortisol levels in saliva, expanding access to mental health assessment.
A breakthrough in medical technology is making it easier for healthcare providers to diagnose depression through rapid, point-of-care testing. Engineers have developed lab-on-a-chip devices that measure cortisol—a key stress hormone—in saliva, providing a non-invasive and accessible diagnostic tool.
These compact tests enable mental health assessments to move beyond traditional clinical settings, bringing vital public health resources closer to patients’ homes. This advancement aligns with a broader global trend toward integrating technology with holistic approaches to mental wellbeing.
Experts believe such innovations will enhance early detection, personalized care, and ongoing monitoring of depression, ultimately transforming how mental health is managed worldwide.
Related topics:
